Treatment with Pradaxa® associated with better patient outcomes after a major bleeding event compared to warfarin
10 December 2012 | By Boehringer Ingelheim
Results from a new post-hoc analysis...
List view / Grid view
10 December 2012 | By Boehringer Ingelheim
Results from a new post-hoc analysis...
10 December 2012 | By Amgen
Amgen and deCODE Genetics announced that the companies have entered into a definitive agreement under which Amgen will acquire deCODE Genetics...
10 December 2012 | By Boehringer Ingelheim
New positive Phase II results...
10 December 2012 | By Gilead Sciences
Gilead Sciences, Inc. announced that its Board of Directors has approved a two-for-one stock split...
10 December 2012 | By Novartis
Latest results from two Phase III clinical trials...
9 December 2012 | By Bristol-Myers Squibb Company
Results from Phase 2 open-label study...
9 December 2012 | By Sanofi
New data presented at American Society of Hematology Annual Meeting show activity against disease and symptom alleviation...
8 December 2012 | By Roche
Roche announced results from two studies...
8 December 2012 | By Roche
Roche announced updated survival results from the Phase III CLEOPATRA study...
8 December 2012 | By Bristol-Myers Squibb Company
Results of the Phase 3 AMPLIFY-EXT trial...
7 December 2012 | By Abbott
Abbott expects to complete separation of AbbVie on Jan. 1, 2013...
7 December 2012 | By Hach Company
Hach Company is pleased to announce the release of the ASX 7200 Autosampler...
6 December 2012 | By Ballou PR
Distribution agreement...
6 December 2012 | By Johnson & Johnson
"We are pleased to present applications..."
5 December 2012 | By Roche
Roche and the IMI launch StemBANCC...